Why Ionis Pharmaceuticals Shares Are Up After Q2 Report

Benzinga
2025.07.30 19:32
portai
I'm PortAI, I can summarize articles.

Ionis 發佈了第二季度每股收益為 85 美分，而預期為 52 美分的虧損，收入為 4.52 億美元，超出市場共識的 2.8295 億美元。2025 財年的收入指引上調至 8.25 億至 8.5 億美元；Tryngolza 的銷售前景上調至 7500 萬至 8000 萬美元。錯過了反彈？瞭解下一批領導者將從何而來

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.